Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children (BREATHE)
Sponsor: Biomedical Research and Training Institute, Zimbabwe
This PHASE3 trial investigates Chronic Lung Disease and HIV Infection and is currently completed. Biomedical Research and Training Institute, Zimbabwe leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jun 2018 — Nov 2019 [monthly]
Recruiting PHASE3
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biomedical Research and Training Institute, Zimbabwe
- London School of Hygiene and Tropical Medicine
- Malawi-Liverpool-Wellcome Trust Clinical Research Programme
- University of Cape Town
- University of Oxford
- University of Tromso
For direct contact, visit the study record on ClinicalTrials.gov .